H. M. Kvasnicka

Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis

Ayalew Tefferi, Srđan Verstovšek, Giovanni Barosi et al. · Journal of Clinical Oncology · 2009 · 191 citations · Full text

Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity

Christian Sittel, Serguei Drago Domínguez Ruiz, P. Volling et al. · Oral Oncology · 1999 · 104 citations

Medicine, Oral Cavity, Pathology +10

Diagnostic differentiation of essential thrombocythaemia from thrombocythaemias associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features--a clinicopathological study on 272 patients.

Jürgen Thiele, H. M. Kvasnicka · PubMed · 2003 · 61 citations

Bone Marrow Features, Diagnosis, Pathology +16

Polycythemia rubra vera versus Secondary Polycythemias. A Clinicopathological Evaluation of Distinctive Features in 199 Patients

J. Thiele, H. M. Kvasnicka, K. Muehlhausen et al. · Pathology - Research and Practice · 2001 · 55 citations

Pathology, A Clinicopathological Evaluation, Distinctive Features +2

The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.

Jürgen Thiele, H. M. Kvasnicka, R Zankovich et al. · PubMed · 2001 · 53 citations

Hematological Malignancy, Polycythemia Vera, Bone Marrow Histology +12